|Pack Size||Qty||Price Per Pill or Unit||Price||Cart|
|30 Tablet/s||US$ 6.76||US$ 202.79|
Doctors may prescribe Erlocip 150 mg for patients with advanced-stage non-small cell lung cancer (NSCLC). It also works to slow or stop the growth of cancer cells in the pancreas. It contains the active ingredient Erlotinib, which works by preventing the activity of a protein called epidermal growth factor receptor (EGFR). This is the protein responsible for the growth and spread of cancer cells. Your doctor may also prescribe Erlocip to you in combination with another treatment called gemcitabine if you have pancreatic cancer at a metastatic stage. You may also receive the anticancer drug if previous chemotherapy has not helped to stop your disease.
Do not take Erlocip 150 mg if you are allergic to erlotinib or any other ingredients of the medicine. If you are taking other medications that affect the way your anti-cancer drug or increase or decrease the amount of drug in the blood, talk to your health care specialist. These drugs may include clarithromycin, phenytoin, rifampicin, omeprazole, ranitidine, barbiturates, protease inhibitors, carbamazepine, St. John’s Wort. Your health care specialist might ask you to avoid using these drugs while you are receiving Erlocip 150 mg. If you are using medicines to prevent blood clotting such as warfarin, Erlotinib may cause you to bleed. Your health care specialist will ask you to monitor you with blood tests on a regular basis. Be careful if you are using statins to control blood pressure, your anti-cancer drug may increase the risk of statin-related muscle problems which may rarely result in kidney damage. Please talk to your health care provider.
It would be best if you told your health care specialist about the difficulty in breathing associated with cough or fever because your health care provider may need to recommend other medicines and discontinue Erlocip. Notify your health care provider if you have diarrhoea because your health care specialists may need to treat the condition with an anti-diarrhoeal drug.
Contact your health care provider if you suffer from diarrhoea or vomiting. Persistent diarrhea may result in low blood potassium and problems with kidney function, particularly when you receive other chemotherapy treatments at the same time. Other common side effects include depression, itching, tiredness, mouth irritation, difficulty breathing, nausea, infection, abnormal blood tests for the liver function. Loss of appetite and cough. If you get any of these side effects to inform your care specialist, this includes possible side effects not mentioned in this information guide.
Always take these medicines exactly as your health care specialist has told you. Check with your health care provider if you are not sure about the usage of the drug. Take the tablet at least one or two hours after having meals. The usual dose is one tablet each day if you have non-small cell lung cancer. For metastatic pancreatic cancer, one tablet in combination with gemcitabine is enough. Talk to your care specialist to know about your dosing regimen.